Skip to content

Powdered Fermented Fruits for Glycemia Reduction

Randomized Pilot Study to Measure the Effects of an Acute Intake of Fermented Fruits Flours on Postprandial Glycaemic Response and Metabolic Profile

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04877548
Acronym
P2F-GR
Enrollment
20
Registered
2021-05-07
Start date
2021-09-07
Completion date
2022-08-01
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiometabolic Risk Factors, Obesity, Abdominal

Keywords

Postprandial glycaemia, Dietary fibers, Cardiometabolic risk, Fermented fruit flour

Brief summary

The aim of the study is to evaluate the effects of an acute intake of two fermented fruits flours as part of a standardized breakfast, in comparison with the acute intake of a standardized breakfast without fermented fruits flour but with the same amount of available carbohydrates, on postprandial glycaemic response and overall metabolism in subjects at cardiometabolic risk. The metabolic parameters will be assessed in fasting and in postprandial period after the consumption of the standardized breakfast.

Interventions

OTHERFermented orange flour

Volunteers will have to consume a standardized breakfast including fermented orange flour and presenting 50g of available carbohydrates

OTHERFermented grape flour

Volunteers will have to consume a standardized breakfast including fermented grape flour and presenting 50g of available carbohydrates

OTHERControl

Volunteers will have to consume a standardized breakfast without fermented flour but also presenting 50g of available carbohydrates

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Body Mass Index between 25 and 35 kg/m2 inclusive * Waist circumference \> 80 cm for women and \> 96 cm for men * Fibers intake ≤ 25g/day

Exclusion criteria

* History of digestive surgery or diseases * Current or recent (\<12 weeks) intake of antibiotics or gastro-intestinal medicinal product * Current probiotics, prebiotics, fibers complement, and/or any products modulating glucose and lipid metabolism * Volunteer with a dietary restriction (vegetarian or high-protein diet for example) * Current weight loss diet * Pregnant or lactating woman or woman who do not use effective contraception * Drinking more than 3 glasses of alcohol per day (\>30g/day) * Smoking volunteer

Design outcomes

Primary

MeasureTime frameDescription
Incremental area under curve (iAUC 0-240 min) of postprandial glycaemia in response to an acute intake of different standardized breakfast including or not a fermented fruits flour but which all contain similar amount of available carbohydrate.Through study completion, an average of 18 daysGlycaemia will be measured at time t-30, 0, 15, 30, 45, 60, 90, 120, 180, 240 (when taking the standardized breakfast).

Secondary

MeasureTime frameDescription
Glycaemia tArea Under Curve/insulinemia tArea Under Curve ratio (0-120 and 0-240 min)Through study completion, an average of 18 daysGlycaemia and insulinemia will be measured at time t-30, 0, 15, 30, 45, 60, 90, 120, 180, 240 (when taking the standardized breakfast).
Maximum value, total and incremental area under curve (iArea Under Curve and tArea Under Curve 0-120, 0-240 and 120-240 min) of digestive hormones (GLP-1 and ghrelin)Through study completion, an average of 18 daysGLP-1 and ghrelin concentrations will be measured at time t-30, 0, 15, 30, 45, 60, 90, 120, 180, 240 and t0, 60, 120, 180, 240 respectively (when taking the standardized breakfast).
Maximum value, total and incremental area under curve (iArea Under Curve and tArea Under Curve 0-240 min) of expired gases (H2, CH4)Through study completion, 24 hours following the last dayExpired gases concentrations will be measured at time t-30, 0, 60, 120, 180, 240, 360, 480, before the diner and the breakfast next day (24 hours following the standardized breakfast intake).
Maximum value, total and incremental area under curve (iArea Under Curve and tArea Under Curve 0-120, 0-240 and 120-240 min) of glycaemia and insulinemiaThrough study completion, an average of 18 daysGlycaemia and insulinemia will be measured at time t-30, 0, 15, 30, 45, 60, 90, 120, 180, 240 (when taking the standardized breakfast).
Satiety and digestive toleranceThrough study completion, 24 hours following the last dayVisual analogue scales (VAS) on gastrointestinal symptoms and questionnaires on the consistency and frequency of stools completed, when taking the standardized breakfast (24 hours following the standardized breakfast intake).
Baseline characteristicsDay 0 (at fasting before the standardized breakfast intake)Anthropometric parameters * height (cm), * waist and hip circumference (cm),
Dietary intakeThrough study completion, an average of 18 daysDietary records completed (the day before and the day of the standardized breakfast intake).
Oxidation of energy substrates (carbohydrates, lipids, proteins) and induced-food thermogenesisThrough study completion, an average of 18 daysIndirect calorimetry measurement during the postprandial period (0-240 min) (when taking the standardized breakfast).

Countries

France

Contacts

Primary ContactNathalie FEUGIER-FAVIER, MD
nathalie.feugier@chu-lyon.fr4 78 86 19 72
Backup ContactJulie-Anne NAZARE, PhD
julie-anne.nazare@univ-lyon1.fr4 78 86 23 22

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026